Skip to content

Feasibility of in vivo image-guided navigation during a robot-assisted prostatectomy

Feasibility of in vivo image-guided navigation during a robot-assisted prostatectomy - Image-guided navigation during robot-assisted prostatectomy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON54359
Enrollment
36
Registered
2021-02-01
Start date
2023-01-11
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer Cancer in the prostate

Interventions

Sponsors

Antoni van Leeuwenhoek (AVL)
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - >= 18 years old - Scheduled for robot-assisted radical prostatectomy - Biopsy-proven prostate carcinoma - Available pre-operative MRI of sufficient quality for making the 3D model - Written and signed informed consent

Exclusion criteria

Exclusion criteria: - Allergic reaction to contrast agents in the past - Metal implants in the pelvic area - Defibrillator or pacemaker implant

Design outcomes

Primary

MeasureTime frame
The main study endpoint is the feasibility of electromagnetic navigation during RARP. Electromagnetic navigation is considered feasible if in 85% of patients the technology can be applied successfully. A successful procedure includes: 1) successful placement of the EM sensors in the prostate and 2) accurate registration between the pre-operative 3D model of the patient and intra-operative situation. The registration is considered accurate if the mean target registration error is 1.0 cm or less. For assessing the accuracy of the registrations a set of independent positions of pre-defined anatomical structures and surfaces is used.

Secondary

MeasureTime frame
The first secondary study parameter is the added time to surgery due to deploying navigation. The second secondary study parameter is the accuracy of the different registration methods.

Countries

Netherlands

Contacts

Public ContactE. Kerkhof

Antoni van Leeuwenhoek (AVL)

trialbureau@nki.nl0205129111

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jun 27, 2026